Popular Trials
Vitamin
Vitamin D + Fish Oil for Health Improvement
This trial is studying whether taking daily dietary supplements of vitamin D3 or omega-3 fatty acids reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses.
Popular Filters
Trials for Hip Osteoarthritis Patients
Orthopedic Implant
Persona Partial Knee Replacement for Osteoarthritis
This trial studies a knee implant called the Persona Partial Knee System in patients needing partial knee replacement. It aims to see how well the implant works and how long it lasts by tracking patients over time. The Persona® system is a newly launched implant designed for knee replacement with innovations intended for better function and higher flexibility.
Trials for OA Patients
Orthopedic Implant
Persona Partial Knee Replacement for Osteoarthritis
This trial studies a knee implant called the Persona Partial Knee System in patients needing partial knee replacement. It aims to see how well the implant works and how long it lasts by tracking patients over time. The Persona® system is a newly launched implant designed for knee replacement with innovations intended for better function and higher flexibility.
Phase 3 Trials
Monoclonal Antibodies
RTX-GRT7039 Injections for Knee Osteoarthritis
This trial uses knee injections called RTX-GRT7039 for patients with knee osteoarthritis who still have pain despite usual treatments. The injections aim to reduce knee pain, possibly by affecting pain pathways or inflammation.
Procedure
TG-C for Knee Osteoarthritis
This trial tests TG-C, an injection into the knee, for people with moderate to severe knee osteoarthritis. It aims to see if TG-C can reduce pain and improve knee function by potentially altering the disease. The study will monitor patients for safety and effectiveness over time. TG-C has been previously studied for its potential to improve knee joint function and reduce pain in osteoarthritis patients.
Procedure
TG-C for Osteoarthritis of the Knee
This trial tests TG-C, an injection into the knee, for patients with moderate to severe osteoarthritis. It aims to reduce pain and improve knee function by potentially modifying the disease. TG-C has shown promise in previous studies for managing knee osteoarthritis.
Stem Cell Therapy
BMAC vs Triamcinolone for Hip Osteoarthritis
This trial compares two treatments for hip osteoarthritis: one that uses the patient's own bone marrow cells to promote healing, and another that uses a steroid to quickly reduce inflammation. The study aims to determine which treatment offers better long-term pain relief and improved mobility.
Glycosaminoglycan (GAG) Analog
Pentosan Polysulfate Sodium Injections for Osteoarthritis
This trial tests if a new treatment can reduce pain and improve function in people with knee osteoarthritis. The medication aims to reduce inflammation and help repair knee joint damage.
Trials With No Placebo
Orthopedic Implant
Persona Partial Knee Replacement for Osteoarthritis
This trial studies a knee implant called the Persona Partial Knee System in patients needing partial knee replacement. It aims to see how well the implant works and how long it lasts by tracking patients over time. The Persona® system is a newly launched implant designed for knee replacement with innovations intended for better function and higher flexibility.
View More Related Trials
Frequently Asked Questions
Introduction to osteoarthritis
What are the top hospitals conducting osteoarthritis research?
Osteoarthritis, a condition characterized by joint pain and stiffness, affects millions of people worldwide. In the quest for innovative treatments and therapies, several top hospitals are leading the way in clinical trials. NYU Langone Health in New york boasts five active osteoarthritis trials, with an impressive history of seven conducted trials since their first recorded study in 2019. Similarly, Brigham and Women's Hospital in Boston has been actively involved in advancing knowledge about this debilitating condition with five ongoing trials and a total of 12 completed studies since their initial investigation back in 2008.
On the West Coast, the University of Washington is making significant strides as well. With four active osteoarthritis trials underway and a notable track record of 11 previous investigations dating back to 2009 when they first embarked on understanding this disease better.The Rush University Medical Center located at Chicago contributes actively too; currently conducting four osteoarthritis clinical tests while holding records from over three decades' worth - thirty-four considered experiments initiated around them since recording their earliest trial related to this field starting way back until2006.
Meanwhile,the Anderson Orthopaedic Research Institute situated Alexandria ensures its presence among these esteemed institutions by participating earnestly through maintaining three ongoing osteoarthritis experimental researches along with having made remarkable contributions across eleven prior cases which can be traced origins earlier as1998.Not only do these hospitals offer hope to individuals suffering from osteoarthritis but collectively they represent collective commitment towards finding more effective ways to manage this chronic condition that impacts daily lives significantly.
With each new trial conducted at these renowned medical centers comes valuable insights into potential breakthroughs for treating and alleviating symptoms associated with osteoarthritis. By working together tirelessly towards discovering cutting-edge interventions,researchers continue pushing boundaries and paving the path towards improved quality of life for those affected by this widespread ailment
Which are the best cities for osteoarthritis clinical trials?
When it comes to osteoarthritis clinical trials, several cities stand out for their ongoing research and opportunities for participation. In New york, there are 24 active trials exploring treatments such as TG-C, Vancomycin powder, and pain coping skills interventions. Chicago offers 19 active trials focused on innovative approaches like low-load treadmill walking exercise and RTX-GRT7039. Miami has 13 active trials investigating treatments such as Pentosan Polysulfate Sodium and intervention options with TG-C. Lastly, in Boston, researchers are conducting 12 studies examining interventions like implicit bias educational modules and arthroscopic partial meniscectomy. These cities provide individuals with osteoarthritis access to cutting-edge clinical trials that could lead to improved treatment options and enhanced quality of life.
Which are the top treatments for osteoarthritis being explored in clinical trials?
Osteoarthritis research is advancing, with several promising treatments currently being explored in clinical trials. Leading the way is a combination of StroMed and platelet rich plasma (PRP), which shows potential as an effective intervention for osteoarthritis. Another contender is RTX-GRT7039, a novel treatment option that holds promise for managing this degenerative joint disease. Additionally, emerging therapies such as cannabidiol (CBD) are also under investigation for their potential to alleviate osteoarthritis symptoms. Finally, adipose-derived (AD) stromal vascular fraction (SVF) therapy presents another avenue worth exploring in the pursuit of effective osteoarthritis treatments. As these clinical trials unfold, hope continues to grow for improved outcomes and better quality of life for individuals suffering from osteoarthritis.
What are the most recent clinical trials for osteoarthritis?
Recent clinical trials have brought new hope to those suffering from osteoarthritis. One groundbreaking study focused on the use of bone marrow aspirate concentrate, which has shown promising results in alleviating symptoms and improving joint function. Another trial investigated the effects of MPL-001, a CBD:THC compound, as a potential treatment for osteoarthritis. Additionally, ketorolac injections delivered directly to affected joints have been explored as an effective method for pain relief. The real IPACK block is another innovative approach being studied for its potential benefits in managing osteoarthritis symptoms. Furthermore, RTX-GRT7039 has emerged as a possible therapeutic option that warrants further investigation and could potentially provide significant relief to individuals living with this debilitating condition.
What osteoarthritis clinical trials were recently completed?
In recent years, multiple clinical trials have been conducted to advance our understanding and treatment options for osteoarthritis. Noteworthy among these studies are the following completed trials: a trial investigating the Sustained Acoustic Device with 2.5% Diclofenac Patch by ZetrOZ, Inc., completed in February 2022; a trial evaluating LY356318 sponsored by Eli Lilly and Company that concluded in October 2021; and another study examining semaglutide 2.4 mg sponsored by Novo Nordisk A/S, also completed in October 2021. These trials demonstrate ongoing efforts to address osteoarthritis through innovative approaches and offer hope for future treatments targeted at this prevalent condition impacting millions worldwide.